Mr. Hamed Shahbazi reports

WELL HEALTH STRENGTHENS CLINICAL AND PUBLIC SECTOR LEADERSHIP WITH APPOINTMENT OF DR. ANDREW BOND AS CHIEF HEALTH OFFICER AND HEAD OF PUBLIC SECTOR

Well Health Technologies Corp. has appointed Dr. Andrew Bond as chief health officer (CHO) and head of public sector, effective immediately. Dr. Bond's appointment reflects Well's increasing focus on partnering with governments and public health systems while advancing clinical governance across its national care delivery and technology platform.

Dr. Bond brings more than two decades of clinical practice and health care leadership experience spanning primary care, hospitalist and emergency medicine, public policy, government relations, and digital health. Most recently, he served as senior vice-president and chief medical officer at GreenShield, where he held broad clinical and administrative leadership responsibilities across one of Canada's leading health and benefits organizations.

Throughout his career, Dr. Bond has held numerous clinical, administrative and academic leadership roles across Ontario, Nunavut and British Columbia. He is a board member of AMS Healthcare, a charitable endowment supporting AI (artificial intelligence) and technology adoption in the health care sector and is a fellow of the College of Family Physicians of Canada. Dr. Bond continues to practise as a primary care physician and serves as a faculty member in the department of family and community medicine at the Temerty Faculty of Medicine, University of Toronto.

Dr. Bond holds a master of health administration (MHA) from the Johnson Shoyama Graduate School of Public Policy at the Universities of Saskatchewan and Regina, a master of business administration (MBA) from the Massachusetts Institute of Technology, and a certified health executive (CHE) designation from the Canadian College of Health Leaders.

Hamed Shahbazi, chairman and chief executive officer of Well commented: "We are pleased to welcome Dr. Bond to Well's executive leadership team. Andrew is an exceptional physician leader with a rare combination of front-line clinical experience, academic depth and executive leadership across some of Canada's most complex health organizations. His expertise in clinical governance, public-sector partnerships, and the responsible deployment of health technology aligns perfectly with Well's mission and our ambitions as a national health care delivery and technology platform. Dr. Bond's appointment comes at an important time as governments and health care organizations increasingly seek trusted partners capable of delivering scalable, secure and AI-enabled health care solutions. We look forward to the significant impact he will have on both our organization and the broader Canadian health system."

Dr. Bond commented: "I am thrilled to be joining Well at such an important time in its transformative growth. Canadians deserve sovereign health solutions that deliver excellent, accessible, integrated and efficient care at scale, deploying the most advanced technologies responsibly and securely. Well is without peer in realizing this ambition across preventive health, diagnostics and medical care through its national clinic network and system enabling technologies. I look forward to working with Well's skilled and purpose-driven staff to continue to accelerate their impact for the health of Canadians and Well's role as a partner in building and sustaining high-performing health systems."

As CHO and head of public sector, Dr. Bond will report directly to Mr. Shahbazi, chairman and CEO, and will work closely with Well's executive leadership team to strengthen clinical governance and performance, advance government and public-sector partnerships, and support the responsible deployment of technology across Well's portfolio. In connection with this appointment, Dr. Bond assumes senior clinical leadership of operations across the Well group of companies, with the company's network of chief medical officers reporting to him. This transition allows Dr. Michael Frankel, who previously served as group chief medical officer, to focus entirely on his role as president of Canadian clinics. In this role, Dr. Bond will lead Well's engagement with federal, provincial and territorial governments, health authorities, and health care stakeholders, helping expand opportunities across digital health infrastructure, health care delivery and AI-enabled clinical solutions in partnership with Wellstar and Healwell AI. Dr. Bond's appointment further strengthens Well's leadership bench as the company continues to expand its role as a technology-enabled health care partner to providers, patients and public health systems across Canada.

About Well Health Technologies Corp.

Well Health Technologies is Canada's largest outpatient health care company and a leading provider of technology-enabled health care solutions. Well is building the infrastructure for a healthier Canada, where every patient gets better care, every provider is empowered by AI, and every piece of health data is protected. Well owns and operates approximately 270 clinics in Canada, supporting more than five million annual patient visits. Through its subsidiary, Wellstar, Well provides electronic medical records, AI-powered clinical tools, patient engagement platforms and IT (information technology) management services. Well provides cybersecurity services through its Cyberwell subsidiary. Well is publicly traded on the Toronto Stock Exchange under the symbol WELL and on the OTC (over-the-counter) exchange under the symbol WHTCF.